These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 24552586)
21. Occupancy of striatal and extrastriatal dopamine D2 receptors by clozapine and quetiapine. Kessler RM; Ansari MS; Riccardi P; Li R; Jayathilake K; Dawant B; Meltzer HY Neuropsychopharmacology; 2006 Sep; 31(9):1991-2001. PubMed ID: 16738543 [TBL] [Abstract][Full Text] [Related]
22. alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs. Kalkman HO; Loetscher E Eur J Pharmacol; 2003 Feb; 462(1-3):33-40. PubMed ID: 12591093 [TBL] [Abstract][Full Text] [Related]
23. Antipsychotic dosing: still a work in progress. Remington G Am J Psychiatry; 2010 Jun; 167(6):623-5. PubMed ID: 20516160 [No Abstract] [Full Text] [Related]
24. Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 1, "Goldilocks" actions at dopamine receptors. Stahl SM J Clin Psychiatry; 2001 Nov; 62(11):841-2. PubMed ID: 11775041 [TBL] [Abstract][Full Text] [Related]
25. Clozapine, ziprasidone and aripiprazole but not haloperidol protect against kainic acid-induced lesion of the striatum in mice, in vivo: role of 5-HT1A receptor activation. Cosi C; Waget A; Rollet K; Tesori V; Newman-Tancredi A Brain Res; 2005 May; 1043(1-2):32-41. PubMed ID: 15862515 [TBL] [Abstract][Full Text] [Related]
26. Mechanism of new antipsychotic medications: occupancy is not just antagonism. Grunder G; Carlsson A; Wong DF Arch Gen Psychiatry; 2003 Oct; 60(10):974-7. PubMed ID: 14557141 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of N-desmethylclozapine as a potential antipsychotic--preclinical studies. Natesan S; Reckless GE; Barlow KB; Nobrega JN; Kapur S Neuropsychopharmacology; 2007 Jul; 32(7):1540-9. PubMed ID: 17164815 [TBL] [Abstract][Full Text] [Related]
28. [No rebound psychosis in a case of switching from clozapine to quetiapine]. Walther S; Baciu D Psychiatr Prax; 2006 Mar; 33(2):93-4. PubMed ID: 16502388 [TBL] [Abstract][Full Text] [Related]
29. The atypical antipsychotic, aripiprazole, blocks phencyclidine-induced disruption of prepulse inhibition in mice. Fejgin K; Safonov S; Pålsson E; Wass C; Engel JA; Svensson L; Klamer D Psychopharmacology (Berl); 2007 Apr; 191(2):377-85. PubMed ID: 17235612 [TBL] [Abstract][Full Text] [Related]
30. Aripiprazole in an animal model of chronic alcohol consumption and dopamine D₂ receptor occupancy in rats. Nirogi R; Kandikere V; Jayarajan P; Bhyrapuneni G; Saralaya R; Muddana N; Abraham R Am J Drug Alcohol Abuse; 2013 Mar; 39(2):72-9. PubMed ID: 23421566 [TBL] [Abstract][Full Text] [Related]
31. In vitro functional characteristics of dopamine D2 receptor partial agonists in second and third messenger-based assays of cloned human dopamine D2Long receptor signalling. Jordan S; Regardie K; Johnson JL; Chen R; Kambayashi J; McQuade R; Kitagawa H; Tadori Y; Kikuchi T J Psychopharmacol; 2007 Aug; 21(6):620-7. PubMed ID: 17092971 [TBL] [Abstract][Full Text] [Related]
32. Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism. Ichikawa J; Li Z; Dai J; Meltzer HY Brain Res; 2002 Nov; 956(2):349-57. PubMed ID: 12445705 [TBL] [Abstract][Full Text] [Related]
33. Contrasting effects of chronic clozapine, Seroquel(TM) (ICI 204,636) and haloperidol administration of deltaFosB-like immunoreactivity in the rodent forebrain. Vahid-Ansari F; Nakabeppu Y; Robertson GS Eur J Neurosci; 1996 May; 8(5):927-36. PubMed ID: 8743740 [TBL] [Abstract][Full Text] [Related]
34. Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophrenia. Gefvert O; Bergström M; Långström B; Lundberg T; Lindström L; Yates R Psychopharmacology (Berl); 1998 Jan; 135(2):119-26. PubMed ID: 9497016 [TBL] [Abstract][Full Text] [Related]
35. Differential profile of antipsychotics at serotonin 5-HT1A and dopamine D2S receptors coupled to extracellular signal-regulated kinase. Bruins Slot LA; De Vries L; Newman-Tancredi A; Cussac D Eur J Pharmacol; 2006 Mar; 534(1-3):63-70. PubMed ID: 16497294 [TBL] [Abstract][Full Text] [Related]
36. BIMG 80, a novel potential antipsychotic drug: evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex. Volonté M; Monferini E; Cerutti M; Fodritto F; Borsini F J Neurochem; 1997 Jul; 69(1):182-90. PubMed ID: 9202309 [TBL] [Abstract][Full Text] [Related]
37. Striatal and extra-striatal D(2)/D(3) dopamine receptor occupancy by quetiapine in vivo. [(123)I]-epidepride single photon emission tomography(SPET) study. Stephenson CM; Bigliani V; Jones HM; Mulligan RS; Acton PD; Visvikis D; Ell PJ; Kerwin RW; Pilowsky LS Br J Psychiatry; 2000 Nov; 177():408-15. PubMed ID: 11059993 [TBL] [Abstract][Full Text] [Related]
38. The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization. Deutch AY; Duman RS Neuroscience; 1996 Jan; 70(2):377-89. PubMed ID: 8848147 [TBL] [Abstract][Full Text] [Related]
39. Opposite function of dopamine D1 and N-methyl-D-aspartate receptors in striatal cannabinoid-mediated signaling. Daigle TL; Wetsel WC; Caron MG Eur J Neurosci; 2011 Nov; 34(9):1378-89. PubMed ID: 22034973 [TBL] [Abstract][Full Text] [Related]
40. Second-generation antipsychotic drugs, olanzapine, quetiapine, and clozapine enhance neurite outgrowth in PC12 cells via PI3K/AKT, ERK, and pertussis toxin-sensitive pathways. Lu XH; Dwyer DS J Mol Neurosci; 2005; 27(1):43-64. PubMed ID: 16055946 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]